{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:15:48Z","timestamp":1793672148683,"version":"4.5.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"am","delay-in-days":283,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jsbmb.2025.106717","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T22:57:18Z","timestamp":1741474638000},"page":"106717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Artifactual elevations of 11\u03b2-hydroxyandrostenedione and 11-ketoandrostenedione in mass spectrometry assays"],"prefix":"10.1016","volume":"250","author":[{"given":"Chaelin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"O\u2019Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Stouffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Auchus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-6190","authenticated-orcid":false,"given":"Adina F.","family":"Turcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2025.106717_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jsbmb.2019.01.018","article-title":"Steroid biomarkers in human adrenal disease","volume":"190","author":"Rege","year":"2019","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jsbmb.2009.12.007","article-title":"Steroid measurement with LC-MS\/MS. Application examples in pediatrics","volume":"121","author":"Rauh","year":"2010","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1373\/clinchem.2007.100008","article-title":"Steroid hormone analysis by tandem mass spectrometry","volume":"55","author":"Soldin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jsbmb.2025.106717_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1055-9965.EPI-09-0643","article-title":"Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens","volume":"19","author":"Faupel-Badger","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jsbmb.2025.106717_bib5","doi-asserted-by":"crossref","first-page":"D1","DOI":"10.1530\/EJE-15-0338","article-title":"Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow","volume":"173","author":"Taylor","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1620\/tjem.253.171","article-title":"Mass Spectrometry-Based Steroid Profiling: Meeting Unmet Clinical Needs","volume":"253","author":"Choi","year":"2021","journal-title":"Tohoku J. Exp. Med"},{"key":"10.1016\/j.jsbmb.2025.106717_bib7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41574-020-0336-x","article-title":"11-Oxygenated androgens in health and disease","volume":"16","author":"Turcu","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib8","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2025.106717_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.119.13866","article-title":"Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping","volume":"75","author":"Turcu","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2025.106717_bib10","first-page":"4589","article-title":"11-ketotestosterone is the dominant circulating bioactive androgen during normal and premature adrenarche","volume":"103","author":"Rege","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2025.106717_bib11","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1210\/jc.2018-02527","article-title":"11-Oxygenated C19 Steroids Do Not Decline With Age in Women","volume":"104","author":"Nanba","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2025.106717_bib12","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1210\/clinem\/dgaa343","article-title":"Sex differences in 11-oxygenated androgen patterns across adulthood","volume":"105","author":"Davio","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2025.106717_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010539","article-title":"Inclusion of 11-oxygenated androgens in a clinical routine LC-MS\/MS setup for steroid hormone profiling","volume":"24","author":"Zeidler","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2025.106717_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jsbmb.2019.04.005","article-title":"Circulating 11-oxygenated androgens across species","volume":"190","author":"Rege","year":"2019","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib16","first-page":"188","article-title":"Classic and 11-oxygenated androgens in serum and saliva across adulthood: a cross-sectional study analyzing the impact of age, body mass index, and diurnal and menstrual cycle variation","author":"Schiffer","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2025.106717_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/EJE-19-0905","article-title":"Abiraterone acetate treatment lowers 11-oxygenated androgens","volume":"182","author":"Wright","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib19","unstructured":"Bioanalytical Method Validatoin - Guidance for industry. \u3008https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf\u3009 (Assessed May 2018)."},{"key":"10.1016\/j.jsbmb.2025.106717_bib20","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b 5 augments the 17, 20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2025.106717_bib21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.steroids.2008.02.001","article-title":"17-Hydroxylase\/C17,20-lyase (CYP17) is not the enzyme responsible for side-chain cleavage of cortisol and its metabolites","volume":"73","author":"Shackleton","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2025.106717_bib22","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-2275(20)37722-1","article-title":"Mode of action of steroid desmolase and reductases synthesized by Clostridium\" scindens\"(formerly Clostridium strain 19)","volume":"25","author":"Winter","year":"1984","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.jsbmb.2025.106717_bib23","first-page":"49","article-title":"Cofactor requirements of steroid-17-20-desmolase and 20\u03b1-hydroxysteroid dehydrogenase activities in cell extracts of Clostridium scindens","volume":"28","author":"Krafft","year":"1987","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib24","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1194\/jlr.M038869","article-title":"Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens","volume":"54","author":"Ridlon","year":"2013","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.jsbmb.2025.106717_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jmii.2022.12.009","article-title":"Clostridium scindens metabolites trigger prostate cancer progression through androgen receptor signaling","volume":"56","author":"Bui","year":"2023","journal-title":"J. Microbiol, Immunol. Infect."},{"key":"10.1016\/j.jsbmb.2025.106717_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/bj0550371","article-title":"The oxidation of corticosteroids with sodium bismuthate","volume":"55","author":"Brooks","year":"1953","journal-title":"Biochem J."},{"key":"10.1016\/j.jsbmb.2025.106717_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1530\/acta.0.0200303","article-title":"The Determination of 17-Ketogenic Steroids in Urine","volume":"20","author":"Tompsett","year":"1955","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/EJE-20-0129","article-title":"Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation","volume":"183","author":"Turcu","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jsbmb.2025.106717_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jsbmb.2025.106717_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cca.2017.05.002","article-title":"Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS\/MS: impact of gender, age, oral contraceptives, body mass index and blood pressure status","volume":"470","author":"Eisenhofer","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jsbmb.2025.106717_bib32","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-21-0348","article-title":"Circadian rhythms of 11-oxygenated C19 steroids and \u22065-steroid sulfates in healthy men","volume":"185","author":"Turcu","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jsbmb.2016.04.012","article-title":"Validation of an LC-MS\/MS salivary assay for glucocorticoid status assessment: Evaluation of the diurnal fluctuation of cortisol and cortisone and of their association within and between serum and saliva","volume":"163","author":"Mezzullo","year":"2016","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib34","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad079","article-title":"Interplay of cortisol, testosterone, and abdominal fat mass in normal-weight women with polycystic ovary syndrome","volume":"7","author":"Dumesic","year":"2023","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.jsbmb.2025.106717_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462228","article-title":"A quantitative analysis of total and free 11-oxygenated androgens and its application to human serum and plasma specimens using liquid-chromatography tandem mass spectrometry","volume":"1650","author":"Caron","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jsbmb.2025.106717_bib36","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1210\/jc.2019-01357","article-title":"Androgens during the reproductive years: what is normal for women?","volume":"104","author":"Skiba","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2025.106717_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105921","article-title":"11-oxygenated androgens and their relation to hypothalamus-pituitary-gonadal-axis disturbances in adults with congenital adrenal hyperplasia","volume":"212","author":"Auer","year":"2021","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106717_bib38","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ18-0212","article-title":"11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome","volume":"65","author":"Yoshida","year":"2018","journal-title":"Endocr. J."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076025000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076025000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:18:51Z","timestamp":1744330731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076025000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":38,"alternative-id":["S0960076025000457"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106717","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artifactual elevations of 11\u03b2-hydroxyandrostenedione and 11-ketoandrostenedione in mass spectrometry assays","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106717"}}